British Journal of Dermatology, volume 168, issue 4, pages 844-854

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

K. A. Papp

C E M Griffiths

K. Gordon

M Lebwohl

P.O. Szapary

Y Wasfi

D. Chan

M C Hsu

V. Ho

P. D. Ghislain

B Strober

K. REICH

Show full list: 12 authors

Publication type: Journal Article

Publication date: 2013-03-25

Wiley

Journal: British Journal of Dermatology

scimago Q1

SJR: 2.759

CiteScore: 16.3

Impact factor: 11

ISSN: 00070963, 13652133

DOI: 10.1111/bjd.12214

Copy DOI

PubMed ID: 23301632

Dermatology

Found

Top-30

Journals

Publishers

	10 20 30 40 50 60 70 80
Wiley	Wiley, 73, 21.66% Wiley 73 publications, 21.66%
Elsevier	Elsevier, 64, 18.99% Elsevier 64 publications, 18.99%
Springer Nature	Springer Nature, 52, 15.43% Springer Nature 52 publications, 15.43%
Taylor & Francis	Taylor & Francis, 39, 11.57% Taylor & Francis 39 publications, 11.57%
Oxford University Press	Oxford University Press, 16, 4.75% Oxford University Press 16 publications, 4.75%
SAGE	SAGE, 11, 3.26% SAGE 11 publications, 3.26%
MDPI	MDPI, 10, 2.97% MDPI 10 publications, 2.97%
Frontiers Media S.A.	Frontiers Media S.A., 6, 1.78% Frontiers Media S.A. 6 publications, 1.78%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 5, 1.48% Ovid Technologies (Wolters Kluwer Health) 5 publications, 1.48%
Korean Society of Gastroenterology	Korean Society of Gastroenterology, 4, 1.19% Korean Society of Gastroenterology 4 publications, 1.19%
Massachusetts Medical Society	Massachusetts Medical Society, 3, 0.89% Massachusetts Medical Society 3 publications, 0.89%
BMJ	BMJ, 3, 0.89% BMJ 3 publications, 0.89%
Remedium, Ltd.	Remedium, Ltd., 3, 0.89% Remedium, Ltd. 3 publications, 0.89%
Georg Thieme Verlag KG	Georg Thieme Verlag KG, 3, 0.89% Georg Thieme Verlag KG 3 publications, 0.89%
American Society for Pharmacology and Experimental Therapeutics	American Society for Pharmacology and Experimental Therapeutics, 2, 0.59% American Society for Pharmacology and Experimental Therapeutics 2 publications, 0.59%
Bentham Science Publishers Ltd.	Bentham Science Publishers Ltd., 2, 0.59% Bentham Science Publishers Ltd. 2 publications, 0.59%
Public Library of Science (PLoS)	Public Library of Science (PLoS), 2, 0.59% Public Library of Science (PLoS) 2 publications, 0.59%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 2, 0.59% Cold Spring Harbor Laboratory 2 publications, 0.59%
American Medical Association (AMA)	American Medical Association (AMA), 2, 0.59% American Medical Association (AMA) 2 publications, 0.59%
Annual Reviews	Annual Reviews, 2, 0.59% Annual Reviews 2 publications, 0.59%
S. Karger AG	S. Karger AG, 1, 0.3% S. Karger AG 1 publication, 0.3%
Mary Ann Liebert	Mary Ann Liebert, 1, 0.3% Mary Ann Liebert 1 publication, 0.3%
Portland Press	Portland Press, 1, 0.3% Portland Press 1 publication, 0.3%
American College of Gastroenterology	American College of Gastroenterology, 1, 0.3% American College of Gastroenterology 1 publication, 0.3%
Baishideng Publishing Group	Baishideng Publishing Group, 1, 0.3% Baishideng Publishing Group 1 publication, 0.3%
Sociedade Brasileira de Coloproctologia	Sociedade Brasileira de Coloproctologia, 1, 0.3% Sociedade Brasileira de Coloproctologia 1 publication, 0.3%
Korean Association for the Study of Intestinal Diseases	Korean Association for the Study of Intestinal Diseases, 1, 0.3% Korean Association for the Study of Intestinal Diseases 1 publication, 0.3%
Editura Academiei Romane/Publishing House of the Romanian Academy	Editura Academiei Romane/Publishing House of the Romanian Academy, 1, 0.3% Editura Academiei Romane/Publishing House of the Romanian Academy 1 publication, 0.3%
Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society	Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society, 1, 0.3% Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society 1 publication, 0.3%
	10 20 30 40 50 60 70 80

We do not take into account publications without a DOI.
Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

67 Field Citation Ratio

11 Relative Citation Ratio

Cite this

GOST |

Cite this

GOST Copy

Papp K. A. et al. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up // British Journal of Dermatology. 2013. Vol. 168. No. 4. pp. 844-854.

GOST all authors (up to 50) Copy

Papp K. A., Griffiths C. E. M., Gordon K., Lebwohl M., Szapary P., Wasfi Y., Chan D., Hsu M. C., Ho V., Ghislain P. D., Strober B., REICH K. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up // British Journal of Dermatology. 2013. Vol. 168. No. 4. pp. 844-854.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1111/bjd.12214

UR - https://doi.org/10.1111/bjd.12214

TI - Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

T2 - British Journal of Dermatology

AU - Papp, K. A.

AU - Griffiths, C E M

AU - Gordon, K.

AU - Lebwohl, M

AU - Szapary, P.O.

AU - Wasfi, Y

AU - Chan, D.

AU - Hsu, M C

AU - Ho, V.

AU - Ghislain, P. D.

AU - Strober, B

AU - REICH, K.

PY - 2013

DA - 2013/03/25

PB - Wiley

SP - 844-854

IS - 4

VL - 168

PMID - 23301632

SN - 0007-0963

SN - 1365-2133

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2013_Papp,

author = {K. A. Papp and C E M Griffiths and K. Gordon and M Lebwohl and P.O. Szapary and Y Wasfi and D. Chan and M C Hsu and V. Ho and P. D. Ghislain and B Strober and K. REICH},

title = {Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up},

journal = {British Journal of Dermatology},

year = {2013},

volume = {168},

publisher = {Wiley},

month = {mar},

url = {https://doi.org/10.1111/bjd.12214},

number = {4},

pages = {844--854},

doi = {10.1111/bjd.12214}

}

MLA

Cite this

MLA Copy

Papp, K. A., et al. “Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.” British Journal of Dermatology, vol. 168, no. 4, Mar. 2013, pp. 844-854. https://doi.org/10.1111/bjd.12214.

Found error?

Message

Support chat

Publisher

Wiley

Journal

British Journal of Dermatology

scimago Q1

SJR

2.759

CiteScore

16.3

Impact factor

ISSN

00070963 (Print)

13652133 (Electronic)

	2 4 6 8 10 12 14
Journal of the American Academy of Dermatology	Journal of the American Academy of Dermatology, 13, 3.86% Journal of the American Academy of Dermatology 13 publications, 3.86%
British Journal of Dermatology	British Journal of Dermatology, 13, 3.86% British Journal of Dermatology 13 publications, 3.86%
Expert Opinion on Biological Therapy	Expert Opinion on Biological Therapy, 11, 3.26% Expert Opinion on Biological Therapy 11 publications, 3.26%
Journal of the European Academy of Dermatology and Venereology	Journal of the European Academy of Dermatology and Venereology, 9, 2.67% Journal of the European Academy of Dermatology and Venereology 9 publications, 2.67%
Cochrane Database of Systematic Reviews	Cochrane Database of Systematic Reviews, 8, 2.37% Cochrane Database of Systematic Reviews 8 publications, 2.37%
American Journal of Clinical Dermatology	American Journal of Clinical Dermatology, 7, 2.08% American Journal of Clinical Dermatology 7 publications, 2.08%
Dermatology and Therapy	Dermatology and Therapy, 7, 2.08% Dermatology and Therapy 7 publications, 2.08%
Inflammatory Bowel Diseases	Inflammatory Bowel Diseases, 7, 2.08% Inflammatory Bowel Diseases 7 publications, 2.08%
Expert Opinion on Drug Safety	Expert Opinion on Drug Safety, 7, 2.08% Expert Opinion on Drug Safety 7 publications, 2.08%
Actas Dermo-Sifiliograficas	Actas Dermo-Sifiliograficas, 6, 1.78% Actas Dermo-Sifiliograficas 6 publications, 1.78%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 5, 1.48% International Journal of Molecular Sciences 5 publications, 1.48%
Drugs	Drugs, 5, 1.48% Drugs 5 publications, 1.48%
Journal of Dermatology	Journal of Dermatology, 5, 1.48% Journal of Dermatology 5 publications, 1.48%
Alimentary Pharmacology and Therapeutics	Alimentary Pharmacology and Therapeutics, 5, 1.48% Alimentary Pharmacology and Therapeutics 5 publications, 1.48%
Dermatologic Therapy	Dermatologic Therapy, 5, 1.48% Dermatologic Therapy 5 publications, 1.48%
Expert Review of Clinical Immunology	Expert Review of Clinical Immunology, 5, 1.48% Expert Review of Clinical Immunology 5 publications, 1.48%
Journal of Crohn's and Colitis	Journal of Crohn's and Colitis, 5, 1.48% Journal of Crohn's and Colitis 5 publications, 1.48%
Journal of Allergy and Clinical Immunology	Journal of Allergy and Clinical Immunology, 4, 1.19% Journal of Allergy and Clinical Immunology 4 publications, 1.19%
Journal of Dermatological Treatment	Journal of Dermatological Treatment, 4, 1.19% Journal of Dermatological Treatment 4 publications, 1.19%
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi	The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 4, 1.19% The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 4 publications, 1.19%
New England Journal of Medicine	New England Journal of Medicine, 3, 0.89% New England Journal of Medicine 3 publications, 0.89%
Journal of Cutaneous Medicine and Surgery	Journal of Cutaneous Medicine and Surgery, 3, 0.89% Journal of Cutaneous Medicine and Surgery 3 publications, 0.89%
Frontiers in Immunology	Frontiers in Immunology, 3, 0.89% Frontiers in Immunology 3 publications, 0.89%
Current Treatment Options in Rheumatology	Current Treatment Options in Rheumatology, 3, 0.89% Current Treatment Options in Rheumatology 3 publications, 0.89%
Journal of Investigative Dermatology	Journal of Investigative Dermatology, 3, 0.89% Journal of Investigative Dermatology 3 publications, 0.89%
Gastroenterology Clinics of North America	Gastroenterology Clinics of North America, 3, 0.89% Gastroenterology Clinics of North America 3 publications, 0.89%
EMC - Podología	EMC - Podología, 3, 0.89% EMC - Podología 3 publications, 0.89%
International Journal of Dermatology	International Journal of Dermatology, 3, 0.89% International Journal of Dermatology 3 publications, 0.89%
Experimental Dermatology	Experimental Dermatology, 3, 0.89% Experimental Dermatology 3 publications, 0.89%
	2 4 6 8 10 12 14